Clinical Significance of CD200 and CD56 Expression in Patients with Acute Myeloid Leukemia.
Salah ArefNashwa AbousamraEmann El-HelalyMohamed MabedPublished in: Asian Pacific journal of cancer prevention : APJCP (2020)
CD200 and CD56 positive expression by myeloblasts at diagnosis denote poor prognostic indicator and correlated with poor cytogenetic findings. CD200 could be used as therapeutic target in AML.<br />.